About Patient Assistance Programs
Breaking down the barriers to accessing complex medication
Bayshore believes that healthcare should be accessible by Canadians. That’s why we partner with healthcare professionals and pharmaceutical manufacturers to connect patients to the support they need, when it matters most.
We treat many diseases and medical conditions in several therapeutic areas, including:
Oncology: lung cancer, breast cancer, renal cell carcinoma (RCC), colorectal cancer (CRC), thyroid cancer, head and neck cancer, chronic myelogenous leukemia (CML), sarcoma, acute lymphocytic leukemia (ALL) / chronic lymphocytic leukemia (CLL), melanoma, non-Hodgkin’s lymphoma (NHL), mantle cell lymphoma (MCL), prostate cancer
Neurology: Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), cervical dystonia (CD) and upper limb spasticity (ULS)
Rheumatology: rheumatoid arthritis (RA), Crohn’s disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, pediatric Crohn’s disease
Rare diseases: Gaucher disease, Hunter syndrome, Fabry disease, hemophilia, growth hormone deficiency, alpha-1 antitrypsin (AAT) deficiency, acromegaly, Duchenne muscular dystrophy (DMD)
Our Services
For Manufacturers
We partner with you to design programs that meet the needs of your patient base
For Patients
Patient assistance or support programs (PAPs or PSPs) exist to get you timely access to medication and to help you stay on track of your therapy